Costamare Inc (CMRE) 9.88 $CMRE Costamare Inc. Announces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Costamare Inc (CMRE) 9.88 $CMRE

Costamare Inc. Announces Availability of Its Annual Report on Form 20-F for the Year Ended December 31, 2015
Marketwired - Wed Apr 27, 7:31AM CDT
Costamare Inc. (the "Company" (NYSE: CMRE) announced today that its Annual Report on Form 20-F for the fiscal year ended December 31, 2015 (the "Annual Report" has been filed with the U.S. Securities and Exchange Commission and can be accessed on the Company's website, www.costamare.com, in the "Investors" section under "Annual Reports".
CMRE: 9.88 (-0.41)

Seaspan Corporation Earnings Float Higher As Its Fleet Continues to Grow
Matthew DiLallo, The Motley Fool - Motley Fool - Tue Apr 26, 7:14AM CDT
Image source: Flickr user Aah-Yeah.   With the bulk of its fleet signed to long-term contracts,  Seaspan has relatively predictable revenue and cash flow. So when it adds a new vessel to its fleet, that addition pushes its revenue and earnings...
CMRE: 9.88 (-0.41), SSW: 15.30 (-0.06)

Costamare beats 1Q profit forecasts
Automated Insights - Wed Apr 20, 3:35PM CDT
ATHENS, Greece (AP) _ Costamare Inc. (CMRE) on Wednesday reported first-quarter profit of $35 million.
CMRE: 9.88 (-0.41)

Costamare Inc. Sets the Date for Its First Quarter 2016 Results Release, Conference Call and Webcast
Marketwired - Fri Apr 15, 8:00AM CDT
Costamare Inc. (NYSE: CMRE), announced today that it will release its results for the first quarter ended March 31, 2016 after the market closes in New York on Wednesday, April 20, 2016. Following the earnings release, Costamare's management team will hold a conference call to discuss the financial results on Thursday, April 21, 2016 at 8:30 a.m. ET.
CMRE: 9.88 (-0.41)

Costamare Inc. Declares Quarterly Dividend on Its Preferred and Common Stock
Marketwired - Fri Apr 01, 8:00AM CDT
Costamare Inc. (the "Company" (NYSE: CMRE) has declared cash dividends of US $0.476563 per share on its 7.625% Series B Cumulative Redeemable Perpetual Preferred Stock (the "Series B Preferred Stock" (NYSE: CMRE PR B), US $0.531250 per share on its 8.50% Series C Cumulative Redeemable Perpetual Preferred Stock (the "Series C Preferred Stock" (NYSE: CMRE PR C) and US $0.546875 per share on its 8.75% Series D Cumulative Redeemable Perpetual Preferred Stock (the "Series D Preferred Stock" (NYSE: CMRE PR D). The dividend for the Series B Preferred Stock, the Series C Preferred Stock and the Series D Preferred Stock is for the period from the most recent dividend payment date, January 15, 2016, to April 14, 2016. The dividends will be paid on April 15, 2016 to all holders of record as of April 14, 2016 of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock.
CMRE: 9.88 (-0.41)

BUYINS.NET: RRTS, USCR, CMRE, TRGP, SCHV, PCEF Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Feb 03, 7:04AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Roadrunner Transportation Systems Inc (NYSE:RRTS), US Concrete Inc (NASDAQ:USCR), Costamare Inc (NYSE:CMRE), Targa Resources Corp (NYSE:TRGP), Schwab U S Large Cap Value ETF (NYSE:SCHV), PowerShares CEF Income Composite Portfolio (NYSECEF) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
RRTS: 7.61 (-0.48), TRGP: 40.70 (-2.42), CMRE: 9.88 (-0.41), USCR: 64.57 (+0.11), SCHV: 44.60 (-0.31), PCEF: 22.30 (-0.08)

Costamare Inc. Sets the Date for Its Fourth Quarter 2015 Results Release, Conference Call and Webcast
Marketwired - Wed Jan 20, 7:30AM CST
Costamare Inc. (NYSE: CMRE), announced today that it will release its results for the fourth quarter ended December 31, 2015 after the market closes in New York on Wednesday, January 27, 2016. Following the earnings release, Costamare's management team will hold a conference call to discuss the financial results on Thursday, January 28, 2016 at 8:30 a.m. ET.
CMRE: 9.88 (-0.41)

BUYINS.NET: WSR, USCR, CMRE, IPHI, TRGP Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Jan 06, 6:42AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Windstorm Resources Inc (NYSE:WSR), US Concrete Inc (NASDAQ:USCR), Costamare Inc (NYSE:CMRE), INPHI CORPORATION (NYSE:IPHI), Targa Resources Corp (NYSE:TRGP) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
IPHI: 32.48 (-0.86), TRGP: 40.70 (-2.42), CMRE: 9.88 (-0.41), WSR: 14.63 (+0.05), USCR: 64.57 (+0.11)

Costamare (CMRE) Looks Good: Stock Moves 8.1% Higher
Zacks Equity Research - Zacks Investment Research - Mon Jan 04, 7:30AM CST
Costamare Inc. (CMRE) was a big mover last session, as the company saw its shares rise over 8% on the day.
ASC: 8.70 (-0.17), CMRE: 9.88 (-0.41)

BUYINS.NET: MXL, WSR, EAA, CMRE, IPHI Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Dec 09, 8:56AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of MaxLinear Inc (NYSE:MXL), Windstorm Resources Inc (NYSE:WSR), (NYSE:EAA), Costamare Inc (NYSE:CMRE), INPHI CORPORATION (NYSE:IPHI) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
EAA: 25.45 (+0.01), IPHI: 32.48 (-0.86), MXL: 20.13 (-0.49), CMRE: 9.88 (-0.41), WSR: 14.63 (+0.05)

3 Reasons Value Stock Investors Will Love Costamare (CMRE)
Zacks Equity Research - Zacks Investment Research - Tue Oct 27, 7:36AM CDT
Costamare (CMRE) is an impressive stock as it has a strong Value Score, favorable Zacks Rank and is also seeing positive estimate revisions.
CMRE: 9.88 (-0.41)

Costamare tops Street 3Q forecasts
Automated Insights - Wed Oct 21, 4:21PM CDT
ATHENS, Greece (AP) _ Costamare Inc. (CMRE) on Wednesday reported third-quarter profit of $34.8 million.
CMRE: 9.88 (-0.41)

Costamare Inc. Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2015
Marketwired - Wed Oct 21, 3:15PM CDT
Costamare Inc. ("Costamare" or the "Company" (NYSE: CMRE) today reported unaudited financial results for the third quarter and nine months ended September 30, 2015.
CMRE: 9.88 (-0.41)

Costamare Inc. Sets the Date for Its Third Quarter 2015 Results Release, Conference Call and Webcast
Marketwired - Fri Oct 16, 8:05AM CDT
Costamare Inc. (NYSE: CMRE), announced today that it will release its results for the third quarter ended September 30, 2015 after the market closes in New York on Wednesday, October 21, 2015. Following the earnings release, on the next day, Thursday, October 22, 2015 at 8:30 a.m. ET, Costamare's management team will hold a conference call to discuss the financial results.
CMRE: 9.88 (-0.41)

Costamare Named Ship Operator of the Year by Lloyds List
Marketwired - Wed Oct 07, 8:15AM CDT
Costamare Inc. (the "Company" (NYSE: CMRE) has been named "Ship Operator of the Year" by Lloyd's List, a global information provider for the shipping industry since 1734.
CMRE: 9.88 (-0.41)

Costamare Inc. Announces Election of Class II Directors at 2015 Annual Meeting of Stockholders
Marketwired - Thu Oct 01, 3:10PM CDT
Costamare Inc. (the "Company" (NYSE: CMRE), an international owner and provider of containerships for charter, announced the election of two Class II directors at the Company's annual meeting of stockholders held in Athens today.
CMRE: 9.88 (-0.41)

Relative Strength Alert For Costamare
DividendChannel.com - Wed Aug 05, 3:04PM CDT
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a...
CMRE: 9.88 (-0.41)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 39

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 46

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 48

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 44

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 50

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 61

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 58

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Cemtrex's Stock Surge Sparks Interest in Leading Movers

Updated Category News Views 117

Cemtrex Experiences Notable Share Surge Shares of Cemtrex, Inc. CETX have seen a significant uptick amid pre-market trading. This boost comes on the heels of better-than-expected sales in the latest quarter, reporting an impressive $18.10 million in sales, surpassing the general analyst expectation of $16.39 million. This remarkable performance in sales has sparked...

Continue Reading
Exciting New PharmD-MBA Pathway Combines Pharmacy and Business

Updated Category News Views 193

Collaboration between Cal Poly Pomona and Western University In an exciting move, Cal Poly Pomona's Singelyn Graduate School of Business and Western University of Health Sciences have teamed up to create a groundbreaking pathway for aspiring healthcare professionals. This innovative PharmD-MBA program combines the fields of pharmacy and business, providing a unique...

Continue Reading
Kaskela Law Investigates Stock Misconduct in Stanley Black & Decker

Updated Category News Views 155

Overview of the Investigation by Kaskela Law LLC Kaskela Law LLC has announced an important investigation focused on Stanley Black & Decker, Inc. (NYSE: SWK) concerning allegations of potential securities fraud. This inquiry is primarily aimed at safeguarding the interests of long-term investors who hold shares in this well-known manufacturing company. Details Surrounding...

Continue Reading
Legend Biotech's Carvykti: A Leading Force in Cancer Treatment

Updated Category News Views 90

Redburn's Positive Outlook for Legend Biotech Recently, Redburn-Atlantic began covering Legend Biotech Corp. (NASDAQ: LEGN) with a favorable Buy rating and set a price target of $86.00 for the stock. This biotechnology company has made significant strides, particularly with the recent approval of its innovative product, Carvykti, designed for the treatment of multiple...

Continue Reading
Transforming the Anti-Obesity Drug Market for Future Success

Updated Category News Views 132

Global Anti-Obesity Drug Market Overview As global health concerns rise, the demand for anti-obesity drugs is surging. Recent reports estimate that the anti-obesity drug market will soar to USD 82.55 billion in the coming years. This impressive growth, fueled by an anticipated compound annual growth rate (CAGR) of 18.01%, signals a crucial moment for pharmaceutical...

Continue Reading